Rabeprazole Sandoz is indicated for the treatment of: Active duodenal ulcer; Active benign gastric ulcer and Anastomotic ulcer; Erosive or ulcerative gastro-oesophageal reflux disease (GERD); Gastro-Oesophageal Reflux Disease Long-term Management (GERD Maintenance); Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GERD); Zollinger-Ellison Syndrome; In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease (see Dosage & Administration); Prevention of Gastric and Duodenal Ulcer Recurrence Associated with Low-dose Aspirin Therapy.